| Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non–small-cell lung cancer VA Miller, MG Kris, N Shah, J Patel, C Azzoli, J Gomez, LM Krug, W Pao, ... Journal of Clinical Oncology 22 (6), 1103-1109, 2004 | 951 | 2004 |
| Developing a cancer‐specific geriatric assessment A Hurria, S Gupta, M Zauderer, EL Zuckerman, HJ Cohen, H Muss, ... Cancer 104 (9), 1998-2005, 2005 | 670 | 2005 |
| The Non–Small Cell Lung Cancer Immune Contexture. A Major Determinant of Tumor Characteristics and Patient Outcome R Remark, C Becker, JE Gomez, D Damotte, MC Dieu-Nosjean, ... American journal of respiratory and critical care medicine 191 (4), 377-390, 2015 | 266 | 2015 |
| Dyadic psychosocial intervention for advanced lung cancer patients and their family caregivers: Results of a randomized pilot trial H Badr, CB Smith, NE Goldstein, JE Gomez, WH Redd Cancer 121 (1), 150-158, 2015 | 211 | 2015 |
| Imatinib mesylate lacks activity in small cell lung carcinoma expressing c‐kit protein LM Krug, JP Crapanzano, CG Azzoli, VA Miller, N Rizvi, J Gomez, MG Kris, ... Cancer 103 (10), 2128-2131, 2005 | 193 | 2005 |
| Effects of obesity on QT, RR, and QTc intervals A El-Gamal, D Gallagher, A Nawras, P Gandhi, J Gomez, DB Allison, ... The American journal of cardiology 75 (14), 956-959, 1995 | 177 | 1995 |
| Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin LM Krug, G Ragupathi, C Hood, MG Kris, VA Miller, JR Allen, SJ Keding, ... Clinical cancer research 10 (18), 6094-6100, 2004 | 171 | 2004 |
| Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines BR Cassileth, GE Deng, JE Gomez, PAS Johnstone, N Kumar, AJ Vickers Chest 132 (3), 340S-354S, 2007 | 147 | 2007 |
| Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall‐cell lung cancer DT Milton, GJ Riely, CG Azzoli, JE Gomez, RT Heelan, MG Kris, LM Krug, ... Cancer 110 (3), 599-605, 2007 | 119 | 2007 |
| A phase I/II study of weekly high‐dose erlotinib in previously treated patients with nonsmall cell lung cancer DT Milton, CG Azzoli, RT Heelan, E Venkatraman, JE Gomez, MG Kris, ... Cancer 107 (5), 1034-1041, 2006 | 112 | 2006 |
| Response and determinants of sensitivity to paclitaxel in human non-small cell lung cancer tumors heterotransplanted in nude mice R Perez-Soler, B Kemp, QP Wu, L Mao, J Gomez, A Zeleniuch-Jacquotte, ... Clinical cancer research 6 (12), 4932-4938, 2000 | 111 | 2000 |
| Pharmacokinetics and toxicity of weekly docetaxel in older patients A Hurria, MT Fleming, SD Baker, WK Kelly, K Cutchall, K Panageas, ... Clinical cancer research 12 (20), 6100-6105, 2006 | 96 | 2006 |
| Decreased resting metabolic rate among persons with Down Syndrome. DB Allison, JE Gomez, S Heshka, RL Babbitt, A Geliebter, K Kreibich, ... International Journal of Obesity and Related Metabolic Disorders: Journal of …, 1995 | 96 | 1995 |
| Cigarette smoking history predicts sensitivity to erlotinib MG Kris, A Sandier, V Miller, M Cespon, M Zakowski, B Pizzo, ... Journal of Clinical Oncology 22, 631s, 2004 | 85* | 2004 |
| Cigarette smoking history predicts sensitivity to erlotinib: results of a phase II trial in patients with bronchioloalveolar carcinoma (BAC) MG Kris, A Sandler, V Miller, M Cespon, M Zakowski, B Pizzo, ... Journal of Clinical Oncology 22 (14_suppl), 7062-7062, 2004 | 85 | 2004 |
| Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma LM Krug, VA Miller, J Patel, J Crapanzano, CG Azzoli, J Gomez, MG Kris, ... Cancer 104 (10), 2149-2155, 2005 | 84 | 2005 |
| Amivantamab in combination with lazertinib for the treatment of osimertinib-relapsed, chemotherapy-naïve EGFR mutant (EGFRm) non-small cell lung cancer (NSCLC) and potential … J Bauml, BC Cho, K Park, KH Lee, EUNK CHO, DW Kim, SW Kim, ... Journal of Clinical Oncology 39 (15_suppl), 9006-9006, 2021 | 79 | 2021 |
| Low spinal and pelvic bone mineral density among individuals with Down syndrome. D Sepúlveda, DB Allison, JE Gomez, K Kreibich, RA Brown, ... American journal of mental retardation: AJMR 100 (2), 109-114, 1995 | 75 | 1995 |
| Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer A Stachnik, T Yuen, J Iqbal, M Sgobba, Y Gupta, P Lu, G Colaianni, Y Ji, ... Proceedings of the National Academy of Sciences 111 (50), 17995-18000, 2014 | 72 | 2014 |
| A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors MG Fury, DB Solit, YB Su, N Rosen, FM Sirotnak, RP Smith, CG Azzoli, ... Cancer chemotherapy and pharmacology 59 (4), 467-475, 2007 | 66 | 2007 |
